Product Information

FINGOLIMOD 0.5 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.3965 per EA under NDC 68462016630. Its NADAC has been published 166 times since Sep 20, 2023.

FDA first approved this application on Jun 18, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FINGOLIMOD 0.5 MG CAPSULE

fingolimod
$1.3965per EA

Strength

.5 mg/1

NDC

68462016630

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

FINGOLIMOD HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA207985

FDA Approved

6/18/2020

TE Code

AB

On Market Since

9/28/2022

Pharmacological Classes

Sphingosine 1-Phosphate Receptor Modulators
Sphingosine 1-phosphate Receptor Modulator

Price Statistics

The NADAC for FINGOLIMOD 0.5 MG CAPSULE has been published 166 times since Sep 20, 2023, and over the history we have for it it has declined 85.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3965 per EA
All-time high$10.0429 (May 15, 2024)
All-time low$1.3965 (Nov 18, 2026)
52-week high$5.7008
52-week low$1.3965
Median price$5.7825
Average price$6.6609
Largest weekly change-27.4% (Jul 22, 2026)
Weeks tracked166
Tracking sinceSep 20, 2023

Price History

1W

-1.8%

1M

-11.6%

3M

-33.4%

6M

-60.8%

1Y

-75.5%

3Y

-85.7%

5Y

N/A

All

-85.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fingolimod market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FINGOLIMOD 0.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for FINGOLIMOD 0.5 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.3965 per EA (NDC 68462016630), effective Nov 18, 2026.

How has the price of FINGOLIMOD 0.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has declined 85.7%. It has been tracked across 166 weekly CMS publications since Sep 20, 2023.

What are the highest and lowest recorded NADAC prices for FINGOLIMOD 0.5 MG CAPSULE?

Since Sep 20, 2023, the NADAC for FINGOLIMOD 0.5 MG CAPSULE has ranged from a low of $1.3965 (Nov 18, 2026) to a high of $10.0429 (May 15, 2024), with a median of $5.7825 per EA.

Are there cheaper alternatives to FINGOLIMOD 0.5 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of FINGOLIMOD 0.5 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures FINGOLIMOD 0.5 MG CAPSULE?

FINGOLIMOD 0.5 MG CAPSULE (NDC 68462016630) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.